Heart Failure with Preserved Ejection Fraction in Women

Anjan Tibrewala, Clyde W. Yancy*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations


Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent condition, particularly in women. Comorbidities, including older age, obesity, diabetes mellitus, hypertension, and hyperlipidemia, are risk factors and define phenotypic profiles of HFpEF in women. The condition has a relatively high burden of morbidity and mortality, with phenotypic profiles potentially characterizing risk of hospitalization and mortality. Based on limited data, nonpharmacologic and pharmacologic treatments may provide benefit; however, compelling evidence-based, disease-modifying treatments are needed. Many unanswered questions about HFpEF in women warrant further investigation to improve understanding of the disease and provide better patient care.

Original languageEnglish (US)
Pages (from-to)9-18
Number of pages10
JournalHeart Failure Clinics
Issue number1
StatePublished - Jan 2019


  • Diastolic heart failure
  • Heart failure with preserved ejection fraction
  • Sex differences
  • Women

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Heart Failure with Preserved Ejection Fraction in Women'. Together they form a unique fingerprint.

Cite this